Drugs that work for one patient may not work for another, even if both patients have the same diagnosis. This is why each patient should be tested to select the most effective and least toxic drug regimen for that individual before initiating treatment.
A panel at MedCity CONVERGE in July will discuss the challenges preventing precision medicine from reaching its full potential and how we can overcome them.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Gianrico Farrugia keynoted this week's Individualizing Medicine Conference at Mayo Clinic with a talk on what to expect in the immediate future of precision medicine.